Literature DB >> 10603210

Serologic evidence of human monocytic and granulocytic ehrlichiosis in Israel.

A Keysary1, L Amram, G Keren, Z Sthoeger, I Potasman, A Jacob, C Strenger, J E Dawson, T Waner.   

Abstract

We conducted a retrospective serosurvey of 1,000 persons in Israel who had fever of undetermined cause to look for Ehrlichia chaffeensis antibodies. Four of five cases with antibodies reactive to E. chaffeensis were diagnosed in the summer, when ticks are more active. All patients had influenzalike symptoms with high fever. None of the cases was fatal. Three serum samples were also seroreactive for antibodies to E. canis, and one was also reactive to the human granulocytic ehrlichiosis (HGE) agent. The titer to the HGE agent in this patient was higher than the serum titer to E. chaffeensis, and the Western blot analysis also indicated that the HGE agent was the primary cause of infection. We present the first serologic evidence that the agents of human monocytic ehrlichiosis (HME) and HGE are present in Israel. Therefore, human ehrlichiosis should be included in the differential diagnoses for persons in Israel who have been exposed to ticks and have influenzalike symptoms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10603210      PMCID: PMC2640796          DOI: 10.3201/eid0506.990605

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  7 in total

1.  First European case of ehrlichiosis.

Authors:  J D Morais; J E Dawson; C Greene; A R Filipe; L C Galhardas; F Bacellar
Journal:  Lancet       Date:  1991-09-07       Impact factor: 79.321

Review 2.  Emerging bacterial zoonotic and vector-borne diseases. Ecological and epidemiological factors.

Authors:  D H Walker; A G Barbour; J H Oliver; R S Lane; J S Dumler; D T Dennis; D H Persing; A F Azad; E McSweegan
Journal:  JAMA       Date:  1996-02-14       Impact factor: 56.272

3.  Human granulocytic ehrlichiosis in Europe.

Authors:  P Brouqui; J S Dumler; R Lienhard; M Brossard; D Raoult
Journal:  Lancet       Date:  1995-09-16       Impact factor: 79.321

4.  Antibodies reactive with Ehrlichia canis, Ehrlichia phagocytophila genogroup antigens and the spotted fever group rickettsial antigens, in free-ranging jackals (Canis aureus syriacus) from Israel.

Authors:  T Waner; G Baneth; C Strenger; A Keysary; R King; S Harrus
Journal:  Vet Parasitol       Date:  1999-03-31       Impact factor: 2.738

5.  Serological evidence of human granulocytic ehrlichiosis in Norway.

Authors:  J S Bakken; J Krueth; R L Tilden; J S Dumler; B E Kristiansen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-10       Impact factor: 3.267

6.  Serologic cross-reactions among Ehrlichia equi, Ehrlichia phagocytophila, and human granulocytic Ehrlichia.

Authors:  J S Dumler; K M Asanovich; J S Bakken; P Richter; R Kimsey; J E Madigan
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

7.  The first isolation, in vitro propagation, and genetic characterization of Ehrlichia canis in Israel.

Authors:  A Keysary; T Waner; M Rosner; C K Warner; J E Dawson; R Zass; K L Biggie; S Harrus
Journal:  Vet Parasitol       Date:  1996-04       Impact factor: 2.738

  7 in total
  8 in total

1.  Stray dogs of northern Jordan as reservoirs of ticks and tick-borne hemopathogens.

Authors:  Moneeb Ahmad Qablan; Michaela Kubelová; Pavel Siroký; David Modrý; Zuhair Sami Amr
Journal:  Parasitol Res       Date:  2012-03-22       Impact factor: 2.289

2.  Case Report: Infectious Diseases in Pilgrims Visiting the Holy Land.

Authors:  Orna Nitzan; Arnon Blum; Esther Marva; Adina Katz; Bat-Sheva Tzadok; Yaarit Nachum-Biala; Gad Baneth; Avi Peretz
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

3.  Serologic and molecular detection of Ehrlichia chaffeensis and Anaplasma phagocytophila (human granulocytic ehrlichiosis agent) in Korean patients.

Authors:  Eun-jeong Heo; Jin-ho Park; Ja-ryong Koo; Man-suk Park; Mi-yeoun Park; J Stephen Dumler; Joon-seok Chae
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

Review 4.  Ehrlichia chaffeensis: a prototypical emerging pathogen.

Authors:  Christopher D Paddock; James E Childs
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

5.  Molecular and clinical evidence of Ehrlichia chaffeensis infection in Cameroonian patients with undifferentiated febrile illness.

Authors:  L M Ndip; M Labruna; R N Ndip; D H Walker; J W McBride
Journal:  Ann Trop Med Parasitol       Date:  2009-12

6.  Detection of Anaplasma phagocytophilum DNA in Ixodes ticks (Acari: Ixodidae) from Madeira Island and Setubal District, mainland Portugal.

Authors:  Ana Sofia Santos; Maria Margarida Santos-Silva; Victor Carlos Almeida; Fátima Bacellar; John Stephen Dumler
Journal:  Emerg Infect Dis       Date:  2004-09       Impact factor: 6.883

7.  Anaplasma phagocytophilum-infected ticks, Japan.

Authors:  Norio Ohashi; Megumi Inayoshi; Kayoko Kitamura; Fumihiko Kawamori; Daizoh Kawaguchi; Yuusaku Nishimura; Hirotaka Naitou; Midori Hiroi; Toshiyuki Masuzawa
Journal:  Emerg Infect Dis       Date:  2005-11       Impact factor: 6.883

8.  Molecular evidence for Anaplasma phagocytophilum in Israel.

Authors:  Avi Keysary; Robert F Massung; Moshe Inbar; Arian D Wallach; Uri Shanas; Kosta Y Mumcuoglu; Trevor Waner
Journal:  Emerg Infect Dis       Date:  2007-09       Impact factor: 6.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.